Table 1.
Circular myotomy (n = 32) | Full-thickness myotomy (n = 24) | P value | ||
Sex, M/F | 13/19 | 11/13 | 0.315 | |
Age (yr) | 41.5 ± 10.8 | 44.5 ± 14.5 | 0.375 | |
Disease course (yr) | 5.3 ± 7.0 | 6.6 ± 8.4 | 0.535 | |
Esophagus type, S/non-S | 1/31 | 3/21 | 0.303 | |
Previous therapy, Yes/No | 6/26 | 5/19 | 0.846 | |
Achalasia type, I/II/III | 5/24/3 | 4/18/2 | 0.987 | |
Pre- | Eckardt score | 6.4 ± 1.3 | 6.5 ± 1.6 | 0.784 |
POEM | LESP, mmHg | 39.5 ± 7.1 | 38.3 ± 6.0 | 0.502 |
4sIRP, mmHg | 28.4 ± 5.0 | 28.7 ± 5.3 | 0.849 | |
Follow-up, mo | 39.8 ± 4.2 | 38.6 ± 1.8 | 0.201 | |
Post- | Eckardt score | 0.47 ± 0.67 | 0.38 ± 0.65 | 0.602 |
POEM | LESP (mmHg) | 14.6 ± 3.7 | 14.0 ± 3.0 | 0.500 |
4sIRP (mmHg) | 10.6 ± 2.8 | 10.2 ± 2.2 | 0.545 | |
GERD symptoms | 15.6% (5/32) | 33.3% (8/24) | 0.12 | |
pH test + | 40.6% (13/32) | 50% (12/24) | 0.485 | |
Esophagitis (%) | 15.6% (5/32) | 29.2% (7/24) | 0.222 | |
Clinically relevant GERD | 12.5% (4/32) | 37.5% (9/24) | 0.028 |
S/non-S: Sigmoid-type/non-sigmoid-type; GERD: Gastroesophageal reflux disease; pH test +: Abnormal esophageal acid exposure.